%0 Journal Article
%T Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer
%A Saito, Motonobu
%A Kono, Koji
%A Kohno, Takashi
%J Translational Lung Cancer Research
%D 2018
%B 2018
%9 
%! Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer
%K 
%X Molecular targeted therapy against driver gene aberrations has a significantly high positive response rate compared with traditional cytotoxic chemotherapies, and has thus dramatically changed the treatment strategies for malignant tumors, including non-small cell lung cancer (NSCLC) (1). Lung adenocarcinoma (LADC) can be treated with targeted therapy against driver gene aberrations using tyrosine kinase inhibitors (TKIs).
%U https://tlcr.amegroups.org/article/view/23560
%P S218-S220
%@ 2226-4477